STOCK TITAN

Sorrento Therapeutics Inc - SRNE STOCK NEWS

Welcome to our dedicated news page for Sorrento Therapeutics (Ticker: SRNE), a resource for investors and traders seeking the latest updates and insights on Sorrento Therapeutics.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Sorrento Therapeutics's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Sorrento Therapeutics's position in the market.

Rhea-AI Summary
Shanghai Escugen Biotechnology released preliminary results from a first-in-human study of ESG401, an innovative ADC, at the ASCO Annual Meeting. ESG401 demonstrated potential advantages in safety, effectiveness, and process robustness. The MTD was not reached, and the most common treatment-related adverse events were leukopenia, neutropenia, anemia, fatigue, and nausea or vomiting. Efficacy results showed partial responses and stable disease in heavily pretreated patients.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.77%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
dividends
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.07%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.07%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
-
Sorrento Therapeutics Inc

Nasdaq:SRNE

SRNE Rankings

SRNE Stock Data

168.36M
Research and Development in Biotechnology
Professional, Scientific, and Technical Services
Link
US
San Diego